EI
MRNA icon

Ellevest Inc’s Moderna MRNA Stock Holding History

Ellevest Inc’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-2,293
Closed -$272K – 442
2024
Q2 		$272K Buy
2,293
+365
+19% +$46.2K 0.02% 331
2024
Q1 		$205K Buy
+1,928
New +$194K 0.01% 372
2023
Q2 		– Sell
-1,105
Closed -$170K – 1138
2023
Q1 		$170K Buy
1,105
+17
+2% +$2.8K 0.01% 347
2022
Q4 		$195K Buy
1,088
+363
+50% +$59.4K 0.02% 304
2022
Q3 		$86K Sell
725
-66
-8% -$10K 0.01% 452
2022
Q2 		$113K Buy
791
+48
+6% +$6.86K 0.01% 387
2022
Q1 		$128K Buy
743
+240
+48% +$40.4K 0.01% 371
2021
Q4 		$128K Buy
503
+482
+2,295% +$141K 0.01% 357
2021
Q3 		$8K Buy
+21
New +$7.75K ﹤0.01% 867
2020
Q3 		– Sell
-25
Closed -$2K – 1246
2020
Q2 		$2K Sell
25
-11
-31% -$602 ﹤0.01% 897
2020
Q1 		$1K Sell
36
-12
-25% -$276 ﹤0.01% 931
2019
Q4 		$1K Buy
+48
New +$852 ﹤0.01% 823

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Ellevest Inc's MRNA Position: Q3 2024 in Review

Ellevest Inc sold out of Moderna (MRNA) in Q3 2024, closing a stake of 2,293 shares — an estimated $272K sold.

Ellevest Inc first reported a position in MRNA in Q4 2019 and held it in 12 quarters. The position peaked at $272K in Q2 2024. 788 funds tracked by Wall St. Rank hold MRNA as of Q3 2024.

  • Ellevest Inc reported no remaining Moderna position as of Q3 2024 after selling out during the quarter.
  • Ellevest Inc sold 2,293 Moderna shares in Q3 2024, an estimated $272K.
  • Ellevest Inc first reported a position in Moderna in Q4 2019 and held it in 12 quarters.
  • Ellevest Inc's Moderna position peaked at $272K in Q2 2024.
  • 788 funds tracked by Wall St. Rank held Moderna as of Q3 2024.

Based on Ellevest Inc's 13F filing for Q3 2024, filed 13 Nov 2024.